Pantoprazol Accord (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Accord, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion and is used to treat conditions such as erosive esophagitis, gastro‑oesophageal reflux disease and peptic ulcer disease in adult patients. GNH USA supplies Pantoprazol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Pantoprazol Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Pantoprazol Accord is a proton pump inhibitor that acts on the acid‑production pathway in the stomach.

- Erosive esophagitis: promotes healing of the esophageal lining by reducing acid exposure. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and prevents further mucosal damage. - Peptic ulcer disease: supports ulcer healing by maintaining a low‑acid gastric environment. - Prevention of NSAID‑induced gastric ulcers: lowers ulcer risk in patients receiving non‑steroidal anti‑inflammatory drugs.

Pantoprazol Accord may cause adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Dizziness

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Clostridioides difficile‑associated colitis - Acute interstitial nephritis - Hepatotoxicity - Low magnesium levels (hypomagnesemia) - Stevens‑Johnson syndrome

When using Pantoprazol Accord, several safety considerations should be observed.

- Assess patient history for hypersensitivity: review any previous allergic reactions to PPIs. - Monitor renal function: patients with renal impairment may require dose adjustment. - Evaluate liver function: hepatic impairment can affect drug clearance. - Use cautiously in pregnancy: limited data, weigh benefits against potential risks. - Store at room temperature: keep in the original packaging, protect from light and moisture.

Pantoprazol Accord can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Co‑administration with clopidogrel: may reduce antiplatelet effect. - Concomitant use with atazanavir or nelfinavir: decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Ketoconazole or itraconazole: reduced absorption of these antifungals. - Methotrex  n t - -   t  t - Digoxin: possible increase in serum levels. - Warfarin: may enhance anticoagulant effect.